The mechanism of action is attributed to the GIP/GLP-1 receptor co-agonism being enhanced by glucagon receptor activation and augmentation of energy intake, substrate utilisation and energy expenditure [60]
Chronic inflammation is a key factor in the development of many diseases, including Type 2 diabetes Cardiovascular disease Some Trusted Source Risk Factors: Chronic Inflammation National Cancer Institute Go to Source cancers Lifestyle modifications like diet and exercise are the cornerstone of obesity management, but GLP-1 can make a huge difference
The development of ED may also be linked to the weight-lowering features of GLP-1 RAs, which can cause significant lean body mass loss, occasionally progressing to sarcopenia, a factor associated with ED [201,202]
They added that the company's drug can also stick around in the body for much longer than current therapies
If you cant afford full mold remediation, move away from a moldy home